BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Job Trends

  Wyeth Plans $280M Powdered Milk Plant in China

  March 11, 2008

   · 

  1 min read
• Pharm Country

  Ortho Biotech Products, L.P. Release: Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia

  March 11, 2008

   · 

  4 min read
• Drug Development

  Opexa Therapeutics Announces Completion of Mid Study Descriptive Analysis on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis

  March 11, 2008

   · 

  5 min read
• Business

  Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.

  March 11, 2008

   · 

  4 min read
• FDA

  Abbott Laboratories Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent New 2.25 mm Diameter Stent Now Available in Europe, Asia and Latin America

  March 11, 2008

   · 

  3 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc. Says Brain Cancer Treatment Shows Promise

  March 11, 2008

   · 

  7 min read
• Business

  ZARS Pharma Announces Worldwide License Agreement With Galderma S.A. for Pliaglis(TM), a Topical Local Anesthetic

  March 11, 2008

   · 

  4 min read
• Drug Development

  ALSERES Pharmaceuticals, Inc. Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics Conference

  March 11, 2008

   · 

  4 min read
• Business

  Cognizant Signs $95M Services Pact with AstraZeneca PLC

  March 11, 2008

   · 

  1 min read
• Drug Development

  OXiGENE Reports Positive Primate Ocular Tolerance and Penetration Data with Topical Formulation of ZYBRESTAT(TM) for Ophthalmology

  March 11, 2008

   · 

  4 min read